Stay Up to Date
Breaking News,
Updates, & More
Click Here to

NCCN Campaign May Prevent Fatal Medication Errors by Targeting Vincristine Preparation

TOP - February 2017, Vol 10, No 1 - Best Practices
Caroline Helwick

Philadelphia, PA—A persistent medi­­cation safety issue is getting the attention it has long deserved. In an effort to save lives related to the accidental intrathecal dosing of vincristine, the National Comprehensive Cancer Network (NCCN) has launched a program called “Just Bag It: The NCCN Campaign for Safe Handling of Vincristine.”

Many agents used in combination with vincristine are delivered intrathe­cally. If vincristine is mistakenly in­­jected into the spine, it is uniformly fatal, as described by speakers at an NCCN press briefing that was intended to increase awareness about this rare but serious and preventable drug safety issue.

According to Michael Cohen, RPh, MS, President of the Institute for Safe Medication Practices, patients experience paralysis and neurologic defects “leading to a very painful and agonizing death.” Accidental injection and resulting death are prevented when vincristine is diluted within an intravenous drip bag and not put into a syringe.

Robert W. Carlson, MD, Chief Executive Officer, NCCN, introduced the campaign by describing his own heartrending experience in caring for a 21-year-old patient with Hodgkin lymphoma. While Dr Carlson was an oncologist at Stanford University, Christopher Wibeto was transferred to his care after having vincristine incorrectly administered at another institution.

“These medical errors are not just statistics. They impact people in a very negative way. It was devastating to know this was happening to Chris because of an error that could have been prevented,” Dr Carlson said.

Christopher’s parents also addressed the media. “When we were told about this campaign, we wanted to do what­­ever we could do to raise awareness about this error so no other family will lose a loved one like we did. Had a procedure for bagging been in place at that time, the error that took Chris would not have happened. We urge all medical facilities to ‘Just Bag It,’” Robin Wibeto commented.

An increasing number of hospitals have adopted a policy to always bag vincristine; however, only 50% of hospitals indicate that the policy is implemented throughout their institutions, an Institute for Safe Medication Practices survey showed.

Dr Carlson said there have been approximately 125 documented cases of accidental death related to incorrect administration of vincristine since the 1960s, but he believes many more go unreported.

Related Items
Complying with Pharmacy Standards: USP 797/USP 800
Gail Thompson
Web Exclusives published on August 7, 2018 in Best Practices
Using Cancer Drugs Wisely to Control Costs: Targeted Therapies May Hold the Key
Gail Thompson
TOP - August 2018, Vol 11, No 2 published on August 3, 2018 in Best Practices
High Rates of Vancomycin-Resistant Enterococci Bacteremia Observed in Patients Receiving Allogeneic Hematopoietic Stem-Cell Transplant
Caroline Helwick
TOP - February 2017, Vol 10, No 1 published on February 1, 2017 in Supportive Care
New Survey Reveals How Pharmacies Manage Verification Processes
Audrey Andrews
TOP - November 2016, Vol 9, No 4 published on November 4, 2016 in Best Practices
Multivitamin Use During Chemotherapy May Reduce Risk for Peripheral Neuropathy
Caroline Helwick
TOP - August 2016, Vol 9, No 3 published on August 3, 2016 in Supportive Care
“Overreaction” to Oxaliplatin Hypersensitivity Reactions
Caroline Helwick
TOP - August 2016, Vol 9, No 3 published on August 3, 2016
Acute Myeloid Leukemia: Understanding the Patient’s Experience
Caroline Helwick
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Hematologic Cancers
LMWH Protocol for Thrombocytopenia Validated in Study
Caroline Helwick
TOP - February 2016, Vol 9, No 1 published on February 12, 2016
Antibacterial Prophylaxis Reduces Infections During Induction Chemotherapy for ALL
Caroline Helwick
TOP - February 2016, Vol 9, No 1 published on February 12, 2016 in Hematologic Cancers
Non-Hodgkin Lymphoma and Hodgkin Lymphoma: The Role of the Nurse Navigator in Improving Patient Outcomes
Peg Rummel, RN, MHA, OCN, NE-BC
Best Practices in Patient Navigation - First Issue: Lymphoma Edition published on May 27, 2015 in Best Practices
Last modified: April 27, 2020